大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/01 | 4,330 | 4,362 | 4,313 | 4,353 | +129 | +3.1% | 786,400 |
2021/02/26 | 4,448 | 4,448 | 4,221 | 4,224 | -161 | -3.7% | 1,186,800 |
2021/02/25 | 4,490 | 4,497 | 4,375 | 4,385 | -35 | -0.8% | 750,800 |
2021/02/24 | 4,504 | 4,504 | 4,413 | 4,420 | -49 | -1.1% | 824,400 |
2021/02/22 | 4,509 | 4,534 | 4,467 | 4,469 | +17 | +0.4% | 522,400 |
2021/02/19 | 4,480 | 4,490 | 4,425 | 4,452 | -77 | -1.7% | 730,600 |
2021/02/18 | 4,550 | 4,565 | 4,495 | 4,529 | +24 | +0.5% | 756,600 |
2021/02/17 | 4,533 | 4,535 | 4,486 | 4,505 | -18 | -0.4% | 629,400 |
2021/02/16 | 4,529 | 4,555 | 4,498 | 4,523 | -7 | -0.2% | 881,000 |
2021/02/15 | 4,600 | 4,615 | 4,482 | 4,530 | -57 | -1.2% | 862,300 |
2021/02/12 | 4,697 | 4,697 | 4,556 | 4,587 | -86 | -1.8% | 1,082,500 |
2021/02/10 | 4,708 | 4,724 | 4,633 | 4,673 | +13 | +0.3% | 810,600 |
2021/02/09 | 4,740 | 4,740 | 4,633 | 4,660 | -83 | -1.7% | 765,800 |
2021/02/08 | 4,694 | 4,747 | 4,663 | 4,743 | +56 | +1.2% | 934,700 |
2021/02/05 | 4,600 | 4,693 | 4,592 | 4,687 | +131 | +2.9% | 913,800 |
2021/02/04 | 4,494 | 4,569 | 4,493 | 4,556 | +44 | +1% | 767,400 |
2021/02/03 | 4,457 | 4,515 | 4,440 | 4,512 | +47 | +1.1% | 595,600 |
2021/02/02 | 4,470 | 4,480 | 4,437 | 4,465 | -55 | -1.2% | 630,400 |
2021/02/01 | 4,479 | 4,526 | 4,440 | 4,520 | +58 | +1.3% | 619,200 |
2021/01/29 | 4,499 | 4,531 | 4,458 | 4,462 | -59 | -1.3% | 842,400 |
2021/01/28 | 4,498 | 4,528 | 4,447 | 4,521 | -23 | -0.5% | 1,326,900 |
2021/01/27 | 4,550 | 4,589 | 4,533 | 4,544 | +46 | +1% | 885,400 |
2021/01/26 | 4,473 | 4,498 | 4,452 | 4,498 | +20 | +0.4% | 500,800 |
2021/01/25 | 4,458 | 4,502 | 4,427 | 4,478 | +65 | +1.5% | 556,500 |
2021/01/22 | 4,400 | 4,427 | 4,374 | 4,413 | -51 | -1.1% | 567,900 |
2021/01/21 | 4,467 | 4,558 | 4,459 | 4,464 | -4 | -0.1% | 814,800 |
2021/01/20 | 4,457 | 4,477 | 4,427 | 4,468 | +11 | +0.2% | 606,300 |
2021/01/19 | 4,429 | 4,478 | 4,397 | 4,457 | +37 | +0.8% | 544,500 |
2021/01/18 | 4,412 | 4,430 | 4,392 | 4,420 | +6 | +0.1% | 486,600 |
2021/01/15 | 4,394 | 4,434 | 4,369 | 4,414 | -7 | -0.2% | 637,500 |
2021/01/14 | 4,367 | 4,445 | 4,355 | 4,421 | +39 | +0.9% | 853,300 |
2021/01/13 | 4,374 | 4,392 | 4,321 | 4,382 | -20 | -0.5% | 842,200 |
2021/01/12 | 4,363 | 4,417 | 4,335 | 4,402 | -3 | -0.1% | 717,900 |
2021/01/08 | 4,341 | 4,411 | 4,314 | 4,405 | +83 | +1.9% | 986,800 |
2021/01/07 | 4,377 | 4,393 | 4,304 | 4,322 | -7 | -0.2% | 1,247,500 |
2021/01/06 | 4,279 | 4,334 | 4,260 | 4,329 | +60 | +1.4% | 545,800 |
2021/01/05 | 4,344 | 4,357 | 4,261 | 4,269 | -48 | -1.1% | 577,500 |
2021/01/04 | 4,402 | 4,404 | 4,300 | 4,317 | -101 | -2.3% | 522,900 |
2020/12/30 | 4,493 | 4,493 | 4,418 | 4,418 | -77 | -1.7% | 555,400 |
2020/12/29 | 4,417 | 4,497 | 4,404 | 4,495 | +21 | +0.5% | 855,900 |
2020/12/28 | 4,502 | 4,522 | 4,461 | 4,474 | +2 | ±0% | 904,200 |
2020/12/25 | 4,496 | 4,502 | 4,468 | 4,472 | +11 | +0.2% | 492,400 |
2020/12/24 | 4,465 | 4,489 | 4,455 | 4,461 | ±0 | ±0% | 463,500 |
2020/12/23 | 4,481 | 4,485 | 4,450 | 4,461 | +18 | +0.4% | 542,600 |
2020/12/22 | 4,457 | 4,495 | 4,439 | 4,443 | -57 | -1.3% | 673,900 |
2020/12/21 | 4,491 | 4,500 | 4,444 | 4,500 | +21 | +0.5% | 591,000 |
2020/12/18 | 4,405 | 4,485 | 4,404 | 4,479 | +67 | +1.5% | 1,033,900 |
2020/12/17 | 4,400 | 4,444 | 4,389 | 4,412 | +5 | +0.1% | 565,000 |
2020/12/16 | 4,461 | 4,477 | 4,403 | 4,407 | -17 | -0.4% | 713,600 |
2020/12/15 | 4,489 | 4,499 | 4,415 | 4,424 | -55 | -1.2% | 599,800 |
1101~
1150
件表示中 / 3596件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 789,300円 | +2.2% | +28.0% | 1.77% | 12.63倍 | 1.53倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
武 田 | 440,200円 | -1.1% | +75.3% | 4.54% | 30.49倍 | 1.00倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
第一三共 | 358,800円 | +6.0% | +4.0% | 2.17% | 22.14倍 | 4.09倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
アステラス薬 | 162,900円 | +0.9% | +380.2% | 4.79% | 22.44倍 | 1.93倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 254,000円 | +20.9% | +10.6% | 2.60% | 12.01倍 | 1.59倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム